Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| IMMU | Immunomedics, Inc. | -0.32% | 85.25 | 11.0% | $715.31m | |
| MRNA | Moderna, Inc. | -0.04% | 70.52 | 0.0% | $666.35m | |
| AMGN | Amgen, Inc. | 0.51% | 248.30 | 1.3% | $659.17m | |
| ILMN | Illumina, Inc. | 0.01% | 305.50 | 3.5% | $626.58m | |
| NVAX | Novavax, Inc. | -2.91% | 107.95 | 96.5% | $605.28m | |
| GILD | Gilead Sciences, Inc. | -1.19% | 62.10 | 1.0% | $578.27m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.30% | 573.61 | 2.7% | $438.99m | |
| BIIB | Biogen, Inc. | 0.11% | 282.35 | 1.6% | $350.80m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.96% | 270.31 | 1.9% | $346.01m | |
| SRNE | Sorrento Therapeutics, Inc. | 14.29% | 11.60 | 1.5% | $320.77m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.74% | 112.46 | 2.0% | $279.94m | |
| EXAS | EXACT Sciences Corp. | 2.32% | 102.01 | 20.7% | $271.56m | |
| SGEN | Seattle Genetics, Inc. | 0.24% | 190.96 | 6.0% | $227.45m | |
| VXRT | Vaxart, Inc. | -2.50% | 6.83 | 0.0% | $197.82m | |
| MNTA | Momenta Pharmaceuticals, Inc. | 0.06% | 52.49 | 3.0% | $177.06m |
Company Profile
Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.